Results of a Statewide Survey of Obstetric Clinician Depression Practices.
Elke Schipani BaileyNancy ByattSmita CarrollLinda BrencklePadma SankaranAimee Kroll-DesrosiersNicole A SmithJeroan AllisonTiffany A Moore SimasPublished in: Journal of women's health (2002) (2021)
Purpose: Perinatal depression affects upwards of one in seven women and is associated with significant negative maternal and child consequences. Despite this, it remains under-detected and under-treated. We sought to identify clinician practices, self-efficacy, and remaining barriers to comprehensively addressing perinatal depression care. Materials and Methods: Surveys were administered to obstetric clinicians in Massachusetts that queried frequency of depression screening and Likert questions about subsequent depression management. Results: Approximately 79.0% of clinicians approached completed the survey. Whereas most clinicians (93.5%) screened for perinatal depression at 6 weeks postpartum, fewer clinicians (66.1%) screened during pregnancy. Most reported they were comfortable providing support to their patients (98.4%), but fewer endorsed being able to treat them on their own (43.0%). Most noted an ability to treat with antidepressants (77.9%); however, fewer endorsed adequate access to nonmedication treatment (45.5%). Conclusions: The majority of surveyed clinicians screen for depression consistent with guidelines. However, efforts are focused on the postpartum period, despite literature citing two-thirds of patients experiencing onset before or during pregnancy. Respondents indicated an ability to treat with medication management, while noting greater challenge with referral. These findings describe the challenges of interdisciplinary coordination as a barrier to comprehensive perinatal mental health care. Clinical Trial Registration Number: NCT02760004.
Keyphrases
- depressive symptoms
- palliative care
- pregnant women
- sleep quality
- healthcare
- clinical trial
- end stage renal disease
- primary care
- ejection fraction
- newly diagnosed
- chronic kidney disease
- systematic review
- randomized controlled trial
- quality improvement
- body mass index
- polycystic ovary syndrome
- bipolar disorder
- pregnancy outcomes
- open label
- study protocol
- adverse drug
- patient reported